RetinalGenix Technologies (RTGN) Cash & Equivalents (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Cash & Equivalents came in at $180.0 in Q1 2026, down 95.15% year-on-year from $3711.0 in Q1 2025, and down 98.78% quarter-over-quarter from $14774.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Cash & Equivalents (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Cash & Equivalents across 7 years of filings, most recently posting $180.0 for Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $180.0, down 95.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.0 (down 95.15% YoY), and the FY2025 annual result was $14774.0, up 143.8% from the prior year.
- Cash & Equivalents came in at $180.0 for Q1 2026 at RetinalGenix Technologies, down from $14774.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $86913.0 in Q2 2024 to a low of $27.0 in Q2 2022.
- The 5-year median for Cash & Equivalents is $3093.5 (2022), against an average of $16107.7.
- Across the five-year window, Cash & Equivalents soared 179647.73% in 2024 and sank 99.88% in 2025, its largest moves.
- RetinalGenix Technologies' Cash & Equivalents stood at $38.0 in 2022, then increased by 15.79% to $44.0 in 2023, then surged by 13672.73% to $6060.0 in 2024, then jumped by 143.8% to $14774.0 in 2025, then tumbled by 98.78% to $180.0 in 2026.
- The last three Cash & Equivalents figures came in at $180.0 (Q1 2026), $14774.0 (Q4 2025), and $92.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 2.45 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | RetinalGenix Technologies | - | - | - | 180.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.00 |
| Dec 31, 2025 | 14,774.00 |
| Sep 30, 2025 | 92.00 |
| Jun 30, 2025 | 839.00 |
| Mar 31, 2025 | 3,711.00 |
| Dec 31, 2024 | 6,060.00 |
| Sep 30, 2024 | 79,089.00 |
| Jun 30, 2024 | 86,913.00 |
| Mar 31, 2024 | 50,386.00 |
| Sep 30, 2023 | 44.00 |
| Jun 30, 2023 | 1,913.00 |
| Mar 31, 2023 | 7,470.00 |
| Dec 31, 2022 | 38.00 |
| Sep 30, 2022 | 3,632.00 |
| Jun 30, 2022 | 27.00 |
| Mar 31, 2022 | 2,555.00 |
| Dec 31, 2021 | 4,947.00 |
| Sep 30, 2021 | 36,578.00 |
| Dec 31, 2020 | 2,219.00 |
| Sep 30, 2020 | 30,090.00 |